Recent APM News
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/14/2026 09:14:32 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 05/14/2026 04:15:15 AM
- Form S-4/A - Registration of securities, business combinations: [Amend] • Edgar (US Regulatory) • 04/30/2026 08:36:32 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/31/2026 08:54:54 PM
- Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)] • Edgar (US Regulatory) • 03/27/2026 08:02:32 PM
- Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend] • Edgar (US Regulatory) • 03/26/2026 08:30:08 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/11/2026 08:00:01 PM
- Aptorum Group and DiamiR Biosciences Announce Publication of microRNA Glioblastoma Biomarker Study in Diagnostics in Collaboration with the University of Pennsylvania • GlobeNewswire Inc. • 03/10/2026 12:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/06/2026 09:30:58 PM
- Aptorum Group Limited Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency • GlobeNewswire Inc. • 03/06/2026 09:30:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/06/2026 09:00:16 PM
- Aptorum Group Announces a Collaboration Between DiamiR Biosciences and Instant NanoBiosensors (INB) to Validate INB’s Automated APOE Testing Platform for Alzheimer’s Disease • GlobeNewswire Inc. • 02/02/2026 01:00:00 PM
- Form S-4/A - Registration of securities, business combinations: [Amend] • Edgar (US Regulatory) • 01/21/2026 10:17:16 PM
- Form F-3 - Registration statement by foreign private issuers • Edgar (US Regulatory) • 01/16/2026 09:30:33 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 12/05/2025 09:30:46 PM
- Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend] • Edgar (US Regulatory) • 12/05/2025 09:30:22 PM
- DiamiR Biosciences and Aptorum Group Announce Two Abstracts Accepted for Presentation at the Clinical Trials on Alzheimer’s Disease (CTAD) 2025 Conference • GlobeNewswire Inc. • 11/19/2025 01:00:00 PM
- Form DEL AM - Delaying amendment • Edgar (US Regulatory) • 11/18/2025 09:30:13 PM
- Form F-1 - Registration statement for certain foreign private issuers • Edgar (US Regulatory) • 11/17/2025 09:31:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 10/16/2025 08:30:02 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 10/15/2025 09:00:39 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 10/14/2025 06:57:55 PM
- Aptorum Group Limited Announces Up To $6 Million Registered Direct Offering • GlobeNewswire Inc. • 10/10/2025 01:54:01 PM
- As part of the planned merger with DiamiR Biosciences, Aptorum Group will expand its board and management team with seasoned executives • GlobeNewswire Inc. • 10/09/2025 12:55:00 PM

